Both in Pharmaceuticals
IGC Pharma vs Edesa Biotech
Over the past year IGC returned −53.8% and EDSA returned +31.0%; their daily moves had a correlation of 0.05.
IGC −53.8% EDSA +31.0%Growth of $1, one year, split-adjusted
| Metric | IGC | EDSA |
|---|---|---|
| Price | $0.1860 | $2.28 |
| Market cap | $19.2M | $22.0M |
| Today | −3.58% | −6.56% |
| 1 month | −34.0% | −41.7% |
| 6 months | −42.3% | −85.2% |
| Year to date | −33.9% | +60.6% |
| 1 year | −52.9% | +22.6% |
| Revenue growth (YoY) | −19.2% | — |
| Gross margin | 18.1% | — |
| Net margin | −1107.9% | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$728.0K | $10.3M |
| Dividend yield | — | — |
| Volatility (60d) | 63.5% | 89.5% |
| Short % of float | 0.7% | 2.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).